NPY Gene Methylation as a Universal, Longitudinal Plasma Marker for Evaluating the Clinical Benefit from Last-Line Treatment with Regorafenib in Metastatic Colorectal Cancer von Jensen, Lars Henrik, Olesen, René, Petersen, Lone Noergaard, Boysen, Anders Kindberg, Andersen, Rikke Fredslund, Lindebjerg, Jan, Nottelmann, Lise, Thomsen, Caroline Emilie Brenner, Havelund, Birgitte Mayland, Jakobsen, Anders, Hansen, Torben Frøstrup

Volltext